ImpleMENTing meditatiOn into heart disease clinical settings (The MENTOR Study)

Not Applicable

Completed

• Conditions: Cardiovascular - Other cardiovascular diseases; Heart disease; depression; anxiety; Alternative and Complementary Medicine - Other alternative and complementary medicine; Cardiovascular - Coronary heart disease; Mental Health - Depression; Mental Health - Anxiety

• Registration Number: ACTRN12618000844246
• Lead Sponsor: niversity of Technology Sydney

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-05-18
• Study Completion: 2018-12-11
• Last Update Posted: 12 September 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 31

Inclusion Criteria

Eligibility Criteria

1.Adults aged 18 or older who have been referred to CR following an acute or chronic cardiac event, or for lifestyle modification;

2.Have at minimum mild to severe depression (DASS-21 score greater than or equal to 5), and/or anxiety (DASS-21 score greater than or equal to 4). People who are currently receiving psychological support and/or medication for their depression and/or anxiety are eligible for inclusion.

3.Willing to give informed consent, and participate in a 6-week group meditation program, adhere to daily home meditation practice using provided resources (CD) and be followed up for 12 months;

4.Level of English literacy to allow completion of study instruments with minimal assistance.

Exclusion Criteria

Adults with congenital heart disease

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Depression as measured by the Depression, Anxiety, Stress (DASS-21) depression subscale[6 weeks post-intervention commencement]